Clinical Trials Directory

Trials / Completed

CompletedNCT06087588

Pericapsular Nerve Group Block Chemical Neurolysis in Advanced Hip Osteoarthritis

The Impact of the Pericapsular Nerve Group Block (PENG) Chemical Neurolysis on the Quality of Life of Patients with Advanced Hip Osteoarthritis. a Randomized, Prospective Double-blinded Clinical Trial.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Poznan University of Medical Sciences · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

PENG neurolysis in advanced osteoarthritis of the hip joint.

Detailed description

The study aims to assess the safety and effectiveness of regional pain treatment methods and their impact on the quality of life of patients with advanced osteoarthritis of the hip joint.

Conditions

Interventions

TypeNameDescription
DRUG0.9%sodium chloridePENG sham block with 20ml 0,9% normal saline
DRUG95% ethanolPENG neurolysis with 2.5ml of 95% ethanol

Timeline

Start date
2023-10-17
Primary completion
2025-01-10
Completion
2025-01-14
First posted
2023-10-18
Last updated
2025-01-21

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT06087588. Inclusion in this directory is not an endorsement.